Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:06:58 EDT Mon 29 Jun 2026
Enter Symbol
or Name
USA
CA



Q:LXRX - LEXICON PHARMACEUTICALS INC - https://www.lexpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
LXRX - Q0.12.38·2.692.02.64+0.093.54,631.211,3929,8762.55  2.6698  2.4852.53  0.800617:46:01Jun 0315 min RT 2¢

Recent Trades - Last 10 of 9876
Time ETExPriceChangeVolume
17:46:01Q2.64820.09821
17:44:08Q2.620.071
17:29:24Q2.640.0914,363
17:21:37Q2.64570.09577
17:17:55Q2.600.0550
17:16:50Q2.64530.095320
17:10:03Q2.650.1025
17:08:15Q2.64980.09981
17:05:09Q2.650.1020
17:03:46Q2.60650.05651

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-03 08:00U:LXRXNews ReleaseLexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
2026-05-28 08:30U:LXRXNews ReleaseLexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
2026-05-12 08:30U:LXRXNews ReleaseLexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
2026-05-07 07:30U:LXRXNews ReleaseLexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates
2026-05-04 16:05U:LXRXNews ReleaseLexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
2026-04-30 08:00U:LXRXNews ReleaseLexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-17 08:00U:LXRXNews ReleaseLexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
2026-03-24 08:00U:LXRXNews ReleaseLexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
2026-03-23 07:30U:LXRXNews ReleaseLexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
2026-03-11 08:00U:LXRXNews ReleaseLexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
2026-03-05 06:59U:LXRXNews ReleaseLexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates
2026-03-03 16:01U:LXRXNews ReleaseLexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
2026-02-26 08:30U:LXRXNews ReleaseLexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026
2026-02-06 17:17U:LXRXNews ReleaseLexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
2026-01-30 02:50U:LXRXNews ReleaseLexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
2026-01-29 16:31U:LXRXNews ReleaseLexicon Announces Proposed Public Offering of Common Stock
2026-01-23 08:30U:LXRXNews ReleaseLexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
2026-01-21 08:30U:LXRXNews ReleaseLexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain
2026-01-12 07:30U:LXRXNews ReleaseLexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference
2026-01-09 08:30U:LXRXNews ReleaseLexicon Pharmaceuticals Publishes "Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain"